Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

The award from the National Institutes of Health will enable a team of researchers to investigate Alzheimer and Parkinson ...

The donation will support the development of the Artificial Intelligence Innovation Center, a collaborative hub with a focus ...

CVD, an AI diagnostic solution that autonomously assesses future cardiovascular disease risk using a retina scan.

Because the inner retinal function is thought to affect the emmetropization process, authors suggested that caffeine may be ...

Adam S. Wenick, MD, PhD, chaired a symposium on geographic atrophy (GA) at EyeCon 2024, focusing on the diagnosis, monitoring ...

In a study, a team of Chinese researchers looked at the mechanisms behind the development of EI and explored effective ...

During a presentation at EyeCon 2024, Jennifer Loh, MD, of Loh Ophthalmology Associates in Miami, Florida, discussed advances ...

At EyeCon 2024, Analisa Arosemena, MD, discussed the shift away from traditional topical therapies towards more proactive ...

David Chin Yee, MD, sat down with Ophthalmology Times to discuss his presentation on what every Optometrist and ...

Johnson & Johnson is expanding the launch of its presbyopia-correcting intraocular lense (IOL) , TECNIS Odyssey, in the US. The TECNIS Odyssey IOL is a new full vision range IOL, built on the TECNIS ...

A collaborative model not only enhances the post-cataract experience but also paves the way for a future where refractive ...